The word Anemia derives from an ancient Greek word anaimia, meaning “lack of blood.”
Anemia, like a fever, is not a diagnosis but a presentation of an underlying disease. Multiple diseases can present as anemia due to various mechanisms.
Anemia affects a significant number of people worldwide (more so in the developing world), resulting in a considerable increase in the cost of medical care.
Anemia can be defined as a reduction in hemoglobin (less than 13.5 g/dL in men; less than 12.0 g/dL in women) or hematocrit (less than 41.0% in men; less than 36.0% in women) or red blood cell (RBC) count. The terms hemoglobin and hematocrit are more commonly used than RBC count in day-to-day clinical practice. There are different lower limits of normal range based on ethnicity, gender, and age.
Anemia causes decreased oxygen-carrying capacity of the blood leading to tissue hypoxia.
Grading of anemia, according to the National Cancer Institute, is as follows:
Anemia classified into acute anemia and chronic anemia. Acute anemia is predominantly due to acute blood loss or acute hemolysis. Chronic anemia is more common and is secondary to multiple causes.
The etiology of chronic anemia is based on mean corpuscular volume. MCV is the average size of RBC.
Microcytic Anemia (MCV less than 80 femtoliters [fL])
Macrocytic Anemia (MCV greater than 100 fL)
Normocytic Anemia (MCV 80 to 100 fL)
Hemolytic anemia may be due to hemolytic uremic syndrome, sickle cell, mechanical heart valves, disseminated intravascular coagulation, cold hemoglobinuria, and cold agglutinin disease.
Some conditions can present in more than one classification. For example, early iron deficiency can be normocytic. Anemia of chronic disease is mostly normocytic but can be microcytic too. Hemolytic anemia can cause either macrocytic or normocytic anemia.
Iron deficiency anemia is the most common type of anemia, affecting approximately 8% to 9% of the world’s population.
Anemia is more prevalent in:
Red blood cells are produced in bone marrow with the help of nutrients (iron, B12, folic acid), cytokines, erythroid-specific GF, and EPO (erythropoietin, produced by kidneys). Once RBCs are released into the blood, they have a lifespan of about 110 to 120 days. Approximately 1% of RBCs are removed every day from the circulation. Under normal conditions, there is a balance between the number RBC released into circulation by the bone marrow to the number removed from circulation. Imbalance of production and release by the bone marrow to loss of RBC leads to anemia as below.
Decreased Red Blood Cell Production
Increased Red Blood Cell Destruction (Hemolytic Anemia)
Inherited hemolytic anemia
Acquired hemolytic anemia
Some conditions can cause anemia by over one mechanism (2 or even all the three mechanisms).
Anemia of chronic disease is a common form of anemia seen in hospitalized patients caused by long-standing diseases, infections, inflammations, and malignancies. These chronic conditions cause increased production of hepcidin by the liver. Hepcidin binds to its receptor ferroportin and decreases intestinal iron absorption and decreases the release of iron from liver and macrophages, leading to decreased availability of iron for erythropoiesis. Other mechanisms that contribute to anemia are by inflammatory cytokines that increase red cell destruction, suppress the proliferation of erythroid precursors, and by inhibiting the release of erythropoietin from kidneys.
CKD is one of the common causes of anemia of chronic disease. The incidence of anemia increases with the progression of CKD, especially from stage III to stage IV and stage V. Erythropoietin is an important hormone needed for erythropoiesis. Anemia causes tissue hypoxia, which, in turn, stimulates erythropoietin production by kidneys. Kidneys produce about 90% of the total erythropoietin, and as CKD progress, its response to hypoxia decreases, causing low erythropoietin levels leading to anemia. CKD can also cause anemia from hemolysis.
Symptoms and signs of chronic anemia are mostly due to decreased tissue oxygenation from the reduction of the oxygen-carrying capacity of the blood. Symptoms are worse when anemia is severe, with a rapid decrease in hemoglobin and hematocrit and with increased oxygen demands states like exercise.
Common presenting symptoms include:
A detailed history should include medical history, home medications, alcohol use, and family history. Ethnicity and country of origin are also helpful.
Important examination findings include:
Mean corpuscular volume (MCV) is a measure of the volume occupied by a single red blood cell. Increased values are seen in macrocytic anemia (vitamin B12 deficiency, folate deficiency, alcohol use), whereas decreased values are seen in microcytic anemia.
Mean corpuscular Hgb concentration reflects the average hemoglobin concentration in RBCs. Increased values are seen in spherocytosis, and low values are seen in thalassemia, iron deficiency, and macrocytic anemia.
The reticulocyte count reflects the presence of nonnucleated immature red blood cells in the bone marrow. Increased levels are seen when there is accelerated erythropoiesis, following anemia, hemorrhage, pregnancy, or splenectomy. Decreased levels indicate lower production and can be a result of aplastic anemia, radiation exposure, or chronic infection.
Differentiation of Microcytic Anemias Based on Iron Studies
Peripheral smear, hemoglobin electrophoresis, and bone marrow examination if needed. Further testing would include esophagogastroduodenoscopy (EGD) and colonoscopy if gastrointestinal (GI) bleeding is suspected and imaging studies if malignancy suspected.
Chronic anemia is managed predominantly in outpatient settings. They need hospitalization if:
If hemoglobin is less than 7 g/dL or if a patent is symptomatic, transfusion of packed red blood cells (PRBC) is indicated.
Transfusions should be done with caution in patients with volume overload status like end-stage renal disease (on hemodialysis) and congestive heart failure (CHF).
Other treatments include treating underlying conditions as below.
Prognosis of anemia varies based on the cause of anemia. Other factors contributing to the prognosis include:
Elderly patients have a poor prognosis due to their advanced age, malnutrition, duration, and multiple comorbidities they tend to have as they age. Patients in the developing world also have a poor prognosis due to malnutrition and lack of access to or delayed medical care.
Hemoglobin less than 6.5 g/dL is life-threatening and can cause death.
Untreated anemia can be life-threatening and can even cause death.
Anemia results in decreased oxygen carrying capacity of the blood. In the short term, a body can compensate with an increase in heart rate and respiratory rate. If left untreated, anemia can cause multi-organ failure. This can include high output heart failure, angina, arrhythmias, cognitive impairment, and renal failure, among others. In pregnant women, untreated anemia can cause premature birth and low birth weight.
Anemia is a condition with decreased oxygen-carrying capacity of the blood. Anemia is very common and caused by different conditions ranging from simple nutritional deficiencies (iron, vitamin B12, and folic acid) to blood loss to other complicated causes.
Anemia is a common medical condition and easily diagnosed with a simple blood work CBC. Treatment can be simple like nutritional supplements (iron, vitamin B12, and folic acid) to blood transfusion to treating complex underlying conditions.
It is very important to follow up with the provider and sometimes with a specialist to treat anemia because untreated anemia can be life-threatening and may even cause death.
Chronic anemia is a very common condition seen in day-to-day clinical practice and managed in outpatient settings. Because of numerous causes, the disorder is best managed by an interprofessional team. Anemia management can range from simple to complex based on the underlying condition causing it.
The patient's primary care physician and nurse practitioner may need the help of a specialist based on the underlying condition, either a gastroenterologist hematologist, nephrologist or gynecologist.
ANy pharmaceutical interventions should have consult from a pharmacist, perhaps even a board-certified pharmacotherapy specialist, who can better guide drug interventions and assist the clinician staff. The social worker should be involved, as some patients may neglect treatment due to a lack of finances. Once the anemia is treated, the primary clinicians need to observe for signs and symptoms of recurrent anemia. The dietitian should educate the patient on eating a healthy diet that consists of fruits and vegetables. The pharmacist should encourage abstinence from alcohol. At every discharge, the nurse should educate the importance of follow up with the relevant specialists.
It is very important to have good interprofessional communication and care coordination for the management of anemia appropriately and promptly. This will help both in correcting anemia and treating underlying conditions.
The outcomes depend on the cause, chronicity, other comorbidities, and the presence of malignancy. [Level 5]
|||Tas F,Eralp Y,Basaran M,Sakar B,Alici S,Argon A,Bulutlar G,Camlica H,Aydiner A,Topuz E, Anemia in oncology practice: relation to diseases and their therapies. American journal of clinical oncology. 2002 Aug [PubMed PMID: 12151968]|
|||Válka J,Čermák J, Differential diagnosis of anemia. Vnitrni lekarstvi. 2018 Summer [PubMed PMID: 30193515]|
|||Baradwan S,Alyousef A,Turkistani A, Associations between iron deficiency anemia and clinical features among pregnant women: a prospective cohort study. Journal of blood medicine. 2018 [PubMed PMID: 30323700]|
|||Lanier JB,Park JJ,Callahan RC, Anemia in Older Adults. American family physician. 2018 Oct 1 [PubMed PMID: 30252420]|
|||Kunireddy N,Jacob R,Khan SA,Yadagiri B,Sai Baba KSS,Rajendra Vara Prasad I,Mohan IK, Hepcidin and Ferritin: Important Mediators in Inflammation Associated Anemia in Systemic Lupus Erythematosus Patients. Indian journal of clinical biochemistry : IJCB. 2018 Oct [PubMed PMID: 30319186]|
|||Anand S,Thomas B,Remuzzi G,Riella M,Nahas ME,Naicker S,Dirks J, Kidney Disease null. 2017 Nov 17 [PubMed PMID: 30212067]|